Americans don't think weight-loss drugs will fix the obesity epidemic

Most Americans who've heard of Ozempic and other new GLP-1 drugs think they can help people with severe weight problems, a new Pew Research Center survey finds.

Why it matters: The public recognizes the injectable treatments' potential to help on the individual level, but they're less convinced that drugs being touted as a major breakthrough — and already upending markets — will put a major dent in America's obesity problem.